Sfoglia per AUTORE
CHEVALLIER P
Collezione AOU Città della Salute di Torino

  

Items : 8

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. in Bone marrow transplantation / Bone Marrow Transplant. 2024 Jan;59(1):52-58. doi: 10.1038/s41409-023-02127-9. Epub 2023 Oct 21.

2024
AOU Città della Salute di Torino

Shadman M; Yáñez San Segundo L; Sadetsky N; Pigneux A; Ljungman P; Kumar D; Guzman-Becerra N; Fagioli F; Chevallier P; García-Cadenas I; Sanz J; Barlev A; Barba P; Socié G; Storek J; Thirumalai D; Xing B; Mohty M;

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis. in HemaSphere / Hemasphere. 2023 Feb 21;7(3):e846. doi: 10.1097/HS9.0000000000000846. eCollection 2023 Mar.

2023
AOU Città della Salute di Torino

Hermans SJF; Versluis J; Labopin M; Giebel S; van Norden Y; Moiseev I; Blaise D; Díez Martín JL; Meijer E; Rovira M; Choi G; Raiola AM; Koc Y; Reményi P; Vydra J; Kröger N; Sica S; Martino M; van Gorkom G; Chevallier P; Busca A; Herrera Arroyo C; Brissot E; Peric Z; Nagler A; Shouval R; Ciceri F; Cornelissen JJ; Mohty M; et alii...

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug

2022
AOU Città della Salute di Torino

Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Nov;57(11):1657-1663. doi: 10.1038/s41409-022-01781-9. Epub 2022 Aug 17

2022
AOU Città della Salute di Torino

Simand C; Carella AM; Kulagin A; Passweg J; Rösler W; Forcade E; Chevallier P; Koc Y; Jindra P; Busca A; Stölzel F; Bulabois CE; Diez-Martin JL; Fanin R; Vydra J; Sica S; Raiola AM; Blaise D; Ciceri F; Tischer J; Labopin M; Baron F; Bazarbachi A; Pioltelli P; Nagler A; Mohty M;

Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Nov;57(11):1747. doi: 10.1038/s41409-022-01856-7.

2022
AOU Città della Salute di Torino

Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M;

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies. in Frontiers in immunology / Front Immunol. 2021 Feb 2;11:613954. doi: 10.3389/fimmu.2020.613954. eCollection 2020.

2020
AOU Città della Salute di Torino

Schoemans H; Kroschinsky F; Yakoub-Agha I; Sengeloev H; Scheid C; Niederwieser D; Ladetto M; Afanasyev B; Corradini P; Kröger N; Castagna L; Rambaldi A; Socié G; Bruno B; Solano C; Chevallier P; Bourhis JH; Ciceri F; Reményi P; Milpied N; Kanfer E; van der Werf S; Blaise D; Beohou E; Jagasia M; Tomaszewska A; Koenecke C; Penack O; Peri? Z; et alii...

Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation. in British journal of haematology / Br J Haematol. 2019 Jan;184(2):294-298. doi: 10.1111/bjh.15074. Epub 2017 Dec 19.

2019
AOU Città della Salute di Torino

Hill A; Tichelli A; Blau IW; Koh MBC; Schouten H; Quarello P; Bruno B; Maury S; Kanfer E; Iacobelli S; Knol C; Peffault de Latour R; Ribera JM; Chevallier P; Medinger M; Kulasekararaj A; Rovó A; Risitano A; Passweg J; Marsh J; Dreger P; Dufour C;

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2016 Sep;22(9):1615-1620. doi: 10.1016/j.bbmt.2016.05.026. Epub 2016 J

2016
AOU Città della Salute di Torino

Bruno B; Socié G; Russell NH; Fegueux N; Lenhoff S; Craddock C; Ljungman P; Cahn JY; Huynh A; Chalandon Y; Chevallier P; Bay JO; Tabrizi R; Yakhoub-Agha I; Passweg JR; Maertens J; Bourhis JH; van Biezen A; Iacobelli S; Potter VT; Meijer E; Mufti GJ; de Witte T; Robin M; Kröger N;